MACQUARIE GROUP LTD - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$509,000
-25.1%
380,0000.0%0.00%0.0%
Q2 2023$680,000
-54.0%
380,0000.0%0.00%
-50.0%
Q1 2023$1,478,000
+14.4%
380,0000.0%0.00%0.0%
Q4 2022$1,292,000
-38.1%
380,000
-0.4%
0.00%
-33.3%
Q3 2022$2,086,000
+21.1%
381,465
-0.2%
0.00%
+50.0%
Q2 2022$1,723,000
-38.8%
382,0410.0%0.00%0.0%
Q1 2022$2,816,000
+14.7%
382,0410.0%0.00%0.0%
Q4 2021$2,456,000
+10.4%
382,0410.0%0.00%0.0%
Q3 2021$2,224,000
-43.6%
382,0410.0%0.00%
-33.3%
Q2 2021$3,943,000
-1.6%
382,041
+0.3%
0.00%
-50.0%
Q1 2021$4,009,000
-32.1%
381,059
-0.1%
0.01%
-33.3%
Q4 2020$5,903,000
+6.0%
381,3320.0%0.01%0.0%
Q3 2020$5,567,000
-22.9%
381,3320.0%0.01%
-25.0%
Q2 2020$7,222,000
-1.1%
381,332
+0.4%
0.01%
-20.0%
Q1 2020$7,300,000
+0.2%
380,0000.0%0.02%
+50.0%
Q4 2019$7,285,000
+99.3%
380,0000.0%0.01%
+66.7%
Q3 2019$3,656,000
-46.5%
380,000
-66.7%
0.01%
+50.0%
Q2 2019$6,828,000
+207.7%
1,140,000
+200.0%
0.00%0.0%
Q1 2019$2,219,000
-37.7%
380,000
-0.1%
0.00%
-42.9%
Q4 2018$3,564,000
-38.1%
380,300
+12.4%
0.01%
-22.2%
Q3 2018$5,759,000
-0.5%
338,200
-0.7%
0.01%
-10.0%
Q2 2018$5,787,000
+64200.0%
340,600
+37744.4%
0.01%
Q4 2017$9,0009000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders